News

Class Action Lawsuit Announced for Charter Communications Investors

Class Action Lawsuit Announced for Charter Communications Investors

Class Action Lawsuit Filed Against Charter Communications

Pomerantz LLP has announced the initiation of a class action lawsuit against Charter Communications, Inc. (CHTR). This legal action targets Charter for potential securities fraud and unlawful business practices that may have impacted investors significantly.

Details of the Class Action

Investors who acquired Charter securities during the designated Class Period are encouraged to take action by contacting Pomerantz to potentially be appointed as Lead Plaintiff. Interested parties should reach out to Danielle Peyton for more information.

Key Dates and Contacts

Investors have until October 13, 2025, to join the lawsuit. Those seeking counsel can connect with Pomerantz at 646-581-9980 for guidance.

Financial Results Raising Concerns

In its recent financial disclosures, Charter reported an EBITDA of $5.7 billion for the second quarter of 2025, signaling just a 0.5% increase compared to the same period last year. However, this minor growth appears to stem from a one-time $45 million boost from 'other revenue.' When excluding this anomaly, the company’s performance faltered, leading to a 2.4% miss against consensus estimates and an actual year-over-year decline of 0.3%.

Customer Base Decline

Charter’s struggles were further highlighted by a significant decline in total Internet customers by 117,000 during the quarter, nearly double the previous quarter’s loss of 66,000. Comparing it to the same period a year prior, the drop feels even more alarming, as it reflects a loss of 99,000 customers. This downward trend has raised alarms among investors and industry analysts alike.

Market Reaction

The announcement of these results on July 25, 2025, triggered a notable reaction in the market, with Charter's stock price plummeting by $70.25, or 18.4%, closing at $309.75. This sharp decline reflects the investors' concern about the company’s sustainability and performance.

About Pomerantz LLP

Pomerantz LLP is recognized as a leading firm specializing in corporate, securities, and antitrust class litigation, founded by Abraham L. Pomerantz, a pioneer in the class action field. With over 85 years dedicated to defending the rights of investors, the firm remains committed to battling securities fraud and similar misconduct. History shows that Pomerantz has successfully recovered millions for their class members.

Frequently Asked Questions

What is the nature of the class action lawsuit?

The class action lawsuit pertains to allegations of securities fraud against Charter Communications and its executives, causing financial loss to investors.

How can I join the class action lawsuit?

Interested investors can contact Pomerantz LLP before the deadline on October 13, 2025, to seek guidance on joining the lawsuit.

What were the recent financial performance results for Charter?

Charter reported a modest increase in EBITDA but also showed significant customer losses, which alarmed investors.

How did the market react to Charter's financial results?

The company’s stock price dropped sharply by 18.4% following the release of disappointing financial results.

Who can I contact for more information about the lawsuit?

Danielle Peyton at Pomerantz LLP is available for inquiries at 646-581-9980, providing necessary information for affected investors.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 29

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 23

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 17

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 16

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 22

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 23

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

Alterity Therapeutics Showcases Innovation at Healthcare Event

Updated Category News Views 142

Alterity Therapeutics to Present at a Virtual Healthcare Conference Alterity Therapeutics, a biotechnology firm dedicated to developing treatments for neurodegenerative diseases, has recently announced its participation in an upcoming healthcare virtual conference. The event will shine a spotlight on influential healthcare companies and their innovative approaches to...

Continue Reading
Important Update for Toronto-Dominion Bank Investors on Lawsuit

Updated Category News Views 58

Update for Investors in Toronto-Dominion Bank Kahn Swick & Foti, LLC, led by the experienced former Louisiana Attorney General Charles C. Foti, Jr., is reminding investors that significant changes are arriving for shareholders of Toronto-Dominion Bank (NYSE: TD). As the legal landscape evolves, those who experienced losses may want to take immediate action regarding their...

Continue Reading
GCC's Quarterly Performance Analysis: Key Insights Revealed

Updated Category News Views 221

GCC Reports Significant First Quarter Financials GCC, S.A.B. de C.V. (BMV: GCC*), recognized as a premier supplier and producer of cement, concrete, and aggregates, has shared its financial results for the first quarter. Despite facing various challenges, GCC's performance metrics reveal a resilience that is noteworthy. Q1 2025 Highlights In the first quarter of 2025, GCC...

Continue Reading
Indonesia's IDX Composite Index Declines Amid Market Pressures

Updated Category News Views 116

Overview of Recent Market Movements in Indonesia Indonesia's stock market experienced a downturn at the close of trading, influenced by various sectors showing significant losses. The IDX Composite Index reflected a decrease of 0.98%, marking a notable dip to a one-month low. This downturn is primarily attributed to declines in several key sectors, including...

Continue Reading
Blink Charging Achieves Advanced Certification for EV Chargers

Updated Category News Views 130

Blink Charging Receives Prestigious OCPP 2.0.1 Certification Blink stands out as one of just five EV charging companies in the U.S. to earn this coveted certification. Bowie, Md. – Blink Charging Co. (NASDAQ: BLNK), a prominent name in electric vehicle (EV) charging equipment and services, has proudly announced that its Series 7, 8, and 9 charger models have...

Continue Reading